<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02623361</url>
  </required_header>
  <id_info>
    <org_study_id>FICB for hip athroscopy</org_study_id>
    <nct_id>NCT02623361</nct_id>
  </id_info>
  <brief_title>A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy</brief_title>
  <official_title>A Prospective Analysis of Preoperative Fascia Iliaca Block for Hip Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing arthroscopic hip surgery have been shown to have significant
      post-operative pain that may delay discharge, recovery, and early mobilisation. A
      pre-operative regional anesthesia technique, the fascia iliaca block may be an effective
      method for acute post-operative analgesia.

      This is a prospective, randomized controlled study of the preoperative fascia iliaca block
      for patients undergoing hip arthroscopy.

      The enrolled patients will be randomized to receive either a fascia iliaca block with the
      local anesthetic ropivacaine or to have a sham block. All patients will receive a general
      anesthetic for the hip arthroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic hip surgery is used to diagnose and treat interior joint pathology. Although
      minimally invasive in nature, patients have considerable amount of pain postoperatively,
      leading to prolonged recovery room stay and increased opiate requirements. The investigators
      performed a retrospective chart review in patients who underwent hip arthroscopy at the UCSF
      Orthopedic Institute. 89% of the patients had pain immediate after surgery requiring opioid
      therapy. Regional anesthesia has previously been shown to reduce discomfort after hip
      arthroscopy. However, there is currently no safe, well-established ultrasound guided regional
      anesthesia technique for arthroscopic hip surgery. The fascia iliaca block has shown to
      decrease acute pain related with hip fractures, as well as pain related with knee
      arthroplasty. The ultrasound guided fascia iliaca block is easy to perform and has an
      excellent safety record. The investigators believe that the ultrasound guided fascia iliaca
      block improves pain control in patients undergoing arthroscopic hip surgery.

      Patients will receive a sham block group or a fascia iliaca block, performed in the
      preoperative area.

      Pain scores and measurement of quadriceps strength will be assessed preoperatively and
      postoperatively. The patient will receive a pain diary consisting of pain scores, pain
      medication consumption, and a brief pain inventory. Within 48 hours postoperatively, an
      anesthesiologist will call the patient and review the patient's pain scores, pain medication
      consumption and brief pain inventory.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Pain Score</measure>
    <time_frame>within one hour after surgery</time_frame>
    <description>highest reported numeric score 0-10 in Post Anesthesia Care Unit (PACU) (primary endpoint) The NRS score is used to rate pain from 0 (no pain) to 10 (worst pain imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leg Strength at Discharge From Ambulatory Center, Surgical Leg</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>measurement of quadriceps strength (Force) using a dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>patient questionaire, patients are contacted 48 h after surgery
patient satisfaction is assessed using a questionnaire, applying a scale from 0 to 10, with 0 indicating &quot;not satisfied at all&quot; and 10 indicating &quot;very satisfied&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Muscle Weakness | Patient</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fascia Iliaca Compartment Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Peripheral Nerve Block</intervention_name>
    <description>Regional Anesthesia by Local Anesthetic Injection</description>
    <arm_group_label>Fascia Iliaca Compartment Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sham Block</intervention_name>
    <description>Sham Block by saline injection</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age at least 18 years old

          -  American Society of Anesthesia physical classification I - III, scheduled for
             arthroscopic hip surgery

        Exclusion Criteria:

          -  Age younger than 18 years old

          -  Non-English speaking

          -  Contraindicated for regional nerve block (such as, but not limited to: coagulopathy,
             infection at site, allergy to local anesthetic)

          -  Preexisting neurologic deficits of operative limb

          -  Need for postoperative nerve function test

          -  Inability to consent due to cognitive dysfunction

          -  Chronic pain

          -  Patient refusal.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Behrends, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopedic Institute</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2015</study_first_posted>
  <results_first_submitted>March 20, 2018</results_first_submitted>
  <results_first_submitted_qc>June 4, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 5, 2018</results_first_posted>
  <last_update_submitted>December 6, 2018</last_update_submitted>
  <last_update_submitted_qc>December 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sham</title>
          <description>Sham Block: Sham Block by saline injection</description>
        </group>
        <group group_id="P2">
          <title>FICB</title>
          <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham</title>
          <description>Sham Block: Sham Block by saline injection</description>
        </group>
        <group group_id="B2">
          <title>FICB</title>
          <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="9"/>
                    <measurement group_id="B2" value="35" spread="11"/>
                    <measurement group_id="B3" value="34" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numeric Pain Score</title>
        <description>highest reported numeric score 0-10 in Post Anesthesia Care Unit (PACU) (primary endpoint) The NRS score is used to rate pain from 0 (no pain) to 10 (worst pain imaginable)</description>
        <time_frame>within one hour after surgery</time_frame>
        <population>Exclusion criteria for enrollment included age younger than 18 years, contraindications for regional anesthesia, pre-existing neurologic deficits of the lower extremity, and a history of chronic pain requiring chronic opioid medication.</population>
        <group_list>
          <group group_id="O1">
            <title>Sham</title>
            <description>Sham Block: Sham Block by saline injection</description>
          </group>
          <group group_id="O2">
            <title>FICB</title>
            <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
          </group>
        </group_list>
        <measure>
          <title>Numeric Pain Score</title>
          <description>highest reported numeric score 0-10 in Post Anesthesia Care Unit (PACU) (primary endpoint) The NRS score is used to rate pain from 0 (no pain) to 10 (worst pain imaginable)</description>
          <population>Exclusion criteria for enrollment included age younger than 18 years, contraindications for regional anesthesia, pre-existing neurologic deficits of the lower extremity, and a history of chronic pain requiring chronic opioid medication.</population>
          <units>units on the numeric rating scale (0-10)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="2"/>
                    <measurement group_id="O2" value="6" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Leg Strength at Discharge From Ambulatory Center, Surgical Leg</title>
        <description>measurement of quadriceps strength (Force) using a dynamometer</description>
        <time_frame>2 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham</title>
            <description>Sham Block: Sham Block by saline injection</description>
          </group>
          <group group_id="O2">
            <title>FICB</title>
            <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
          </group>
        </group_list>
        <measure>
          <title>Leg Strength at Discharge From Ambulatory Center, Surgical Leg</title>
          <description>measurement of quadriceps strength (Force) using a dynamometer</description>
          <units>Newton</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139" spread="99"/>
                    <measurement group_id="O2" value="41" spread="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>patient questionaire, patients are contacted 48 h after surgery
patient satisfaction is assessed using a questionnaire, applying a scale from 0 to 10, with 0 indicating &quot;not satisfied at all&quot; and 10 indicating &quot;very satisfied&quot;</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham</title>
            <description>Sham Block: Sham Block by saline injection</description>
          </group>
          <group group_id="O2">
            <title>FICB</title>
            <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>patient questionaire, patients are contacted 48 h after surgery
patient satisfaction is assessed using a questionnaire, applying a scale from 0 to 10, with 0 indicating &quot;not satisfied at all&quot; and 10 indicating &quot;very satisfied&quot;</description>
          <units>units on the numeric rating scale (0-10)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="0"/>
                    <measurement group_id="O2" value="10" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sham</title>
          <description>Sham Block: Sham Block by saline injection</description>
        </group>
        <group group_id="E2">
          <title>FICB</title>
          <description>Peripheral Nerve Block: Regional Anesthesia by Local Anesthetic Injection</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Matthias Behrends, PI</name_or_title>
      <organization>UCSF</organization>
      <phone>415 476 3761</phone>
      <email>matthias.behrends@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

